Table 1.
The clinical and demographic characteristics of study participants.
| PJP patients (n = 40) | non-PJP patients (n = 40) | |
|---|---|---|
| Age, years, median (25th - 75th centiles) | 52 (44-61) | 48 (43-56) |
| Males, n (%) | 26 (65) | 26 (65) |
| Patient sources, n (%) | ||
| Solid organ transplant | 7 (17.5) | 6 (15) |
| Autoimmune disease | 33 (82.5) | 34 (85) |
| Clinical presentation | ||
| Cough | 22 (55) | 0 (0) |
| Fever | 12 (30) | 0 (0) |
| Chest distress | 11 (27.5) | 0 (0) |
| Radiological findings | ||
| Lung shadow | 32 (80) | 0 (0) |
| Lung nodules | 7 (17.5) | 0 (0) |
| Pleural effusion | 18 (45) | 0 (0) |
| Maintenance immunosuppressive regimen, n (%) | ||
| Corticosteroids (convert to methylprednisolone) ≥ 20mg/day | 39 (97.5) | 38 (95) |
| Tacrolimus | 6 (15) | 4 (10) |
| Cyclophosphamide | 6 (15) | 9 (22.5) |
| Mycophenolate Mofetil | 1 (2.5) | 3 (7.5) |
| Underlying condition or illness, n (%) | ||
| Smoking | 9 (22.5) | 8 (20) |
| Drinking | 3 (7.5) | 3 (7.5) |
| HIV | 0 (0) | 0 (0) |
| Diabetes mellitus | 5 (12.5) | 6 (15) |
| Hypertension | 17 (42.5) | 16 (40) |
| Chronic pulmonary disease | 4 (10) | 0 (0) |
| Chronic kidney disease | 13 (32.5) | 40 (100) |
| Chronic heart failure | 1 (2.5) | 1 (2.5) |
PJP, Pneumocystis jiroveci pneumonia; HIV, human immunodeficiency virus; Data are presented as number (percentage), means ± SD, or medians (25th - 75th centiles).